Ask AI

Research Focus: Targeting Tropomyosin Receptor Kinases in Cancer

In this educational activity with an accompanying PowerPoint slideset Todd M. Bauer MD provides his expert perspective on the biological rationale for targeting TRK in the treatment of diverse cancers with NTRK gene fusions including a review of the latest clinical data on investigational TRK inhibitors.

Share

Program Content

No activities added yet

Supporters

This activity is supported by an educational grant from

Loxo Oncology